{
  "ticker": "BAX",
  "company_name": "Baxter International",
  "summary": "Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations Refer to our Annual Report on Form 10-K for the year ended December 31, 2024 (2024 Annual Report) for management’s discussion and analysis of our financial condition and results of operations. The following is management’s discussion and analysis of our financial condition and results of operations for the three and nine months ended September 30, 2025 and 2024. COMPLETED STRATEGIC ACTIONS Since January 2023, we have completed several strategic actions, as discussed below. Sale of Kidney Care Business On August 12, 2024, we entered into an Equity Purchase Agreement (EPA) with certain affiliates of Carlyle Group Inc."
}